The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally with 146 affiliates and a total of more than 47,700 employees. The focus of the family-owned company, founded in 1885, is researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine.
For more information, visit https://www.boehringer-ingelheim.com.au
Tuesday 13th November, 5.30pm AEST
What is the GP’s role in diagnosing and treating atrial fibrillation (AF)? Join Dr Bradley Wilsmore in this free webinar to find out!